Tanaproget derivatives, metabolites, and uses thereof

Details Tanaproget derivatives, metabolites, and uses thereof Tanaproget derivatives, metabolites, and uses thereof

2005-08-11

2009-08-04

Lau, Jonathan S (Department: 1623)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

C536S018600

Reexamination Certificate

active

07569679

ABSTRACT:
A method of generating synthetic metabolites of tanaproget derivatives thereof is provided. These compounds and methods of using these derivatives for detecting tanaproget metabolites in samples are provided.

REFERENCES:
patent: 6436929 (2002-08-01), Zhang et al.
patent: 2004/0006060 (2004-01-01), Fensome et al.
patent: WO 00/22000 (2000-04-01), None
patent: WO 00/66570 (2000-11-01), None
patent: WO 01/77093 (2001-10-01), None
patent: WO 04/000801 (2003-12-01), None
Han, H.-K. and Amidon, G.L. “Targeted Prodrug Design to Optimize Drug Delivery”, AAPS Pharmsci, 2000, 2, p. 1-11.
Volin, Journal of Chromatography B, 1995, 671, p. 319-340.
Zhang et al, Novel 6-Aryl-1, 4-dihydrobenxo[d][1,3]Ozaxine-2-Thiones as Potent, Selective, and Orally Active Nonsteroidal Progesterone Receptor Agonists, Bioorganic & Medicinal Chemistry Letter 13, pp. 1313-1316, (Apr. 7, 2003).
Winneker et al, Nonsteroidal Progesterone Receptor Modulators: Structure Activity Relationships, Seminars in Reproductive Medicine, vol. 23, No. 1, (Feb. 2005).
Fensome et al, Synthesis and Structure-Activity Relationship of Novel 6-Aryl-1,4-Dihydrobenzo[d][1,3]Oxazine-e-Thiones as Progesterone Receptor Modulators Leading to the Potent and Selective Nonsteroidal Progesterone Receptor Agoinst Tanaproget, J. Med. Chem. (Aug. 11, 2005), 48, pp. 5092-5095.
Keating et al. “NMR Characterization of an S-Linked Glucuronide Metabolite of the Potent, Novel, Nonsteroidal Progesterone Agonists Tanaproget”, Drug Metab. Disposition, 34(8):1283 (2006; e-pub: May 12, 2006).
Elmarakby et al., “Glucuronidation of Tanaproget, A Potent Non-Steroidal Progesterone Receptor Agonists, by Human UDP-Glucuronosyltransferases 1A9 and 2B7”, AAPS J, 7(S2):W5266 (Abstract of presentation on Apr. 29, 2005).
Zhang et al., “Molecular and Pharmacological Properties of a Potent and Selective Novel Nonsteroidal Progesterone Receptor Agonist Tanaproget”, J. Biol. Chem., J. Biol. Chem., 280(31):28468-75 (Aug. 5, 2005; e-pub: Jun. 3, 2005).

Affiliated with

Also associated with

Rating

Tanaproget derivatives, metabolites, and uses thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Tanaproget derivatives, metabolites, and uses thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tanaproget derivatives, metabolites, and uses thereof will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4056086